Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

What modern physicians can learn from Hippocrates

Stanley Joel Reiser¹

¹Program on Humanities and Technology in Health Care, The University of Texas Health Science Center at Houston, Houston, TX 77225, USA. Stanley.J.Reiser@uth.tmc.edu

|October 10, 2003

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The concept of service in medicine.

Journal of pain and symptom management·2012

Same author

Research compensation and the monetarization of medicine.

JAMA·2005

Same author

The social responsibilities of biological scientists.

Science and engineering ethics·1997

Same author

Protecting research subjects after consent: the case for the "research intermediary.

IRB·1993

Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026

Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026

Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026

Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026

Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026

Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026

See all related articles